HTPU microarray services
Providing insights into the genetic and molecular basis of disease.
The MRC Institute of Genetics and Molecular Medicine/Cancer Research UK Edinburgh Centre houses cutting edge protein, antibody and transcriptomic microarray facilities for the analysis of complex signalling pathways and secreted factors (e.g. chemokines/cytokines) across multiple pre-clinical and clinical sample types. Our facility brings together industry leading platforms, like the high throughput Quanterix-2470-microarrayer, Innopsys 710 infra-red microarray scanner, Zeptosens RPPA system, and NanoString.
The technologies we offer in this facility are
- Reverse Phase Protein Arrays
- Forward Phase Antibody Microarrays
- NanoString
Each microarray platform enables rapid and robust quantification of biomarkers at transcriptomic and post-translational pathway levels across multiple sample sets. Study size can be scaled to the needs of the experiment.
People |
|
| Professor Neil Carragher | Academic Lead |
| Alison Munro | Facility Manager |
| Camilla Drake | Research Technician |
Our facilities are available to all within the University of Edinburgh, and also to external groups through funded collaboration or fee-for-service contract.
NanoString
Reverse Phase Protein Arrays
Forward Phase Antibody Microarrays
